The United States, in partnership with the COVID-19 Vaccines Global Access (COVAX) facility, donated an additional 2,703,870 doses of the Pfizer-BioNTech COVID-19 vaccine to the Philippines as part of its relentless worldwide effort to help end COVID-19, particularly amid the threat of the Omicron variant.
The vaccines, which arrived in Manila on January 9, were part of the 500 million Pfizer doses the United States is making available for distribution through COVAX, a global initiative to support equitable access to COVID-19 vaccines. As the largest donor to the COVAX facility, the United States has facilitated the delivery of over 65 million COVID-19 vaccine doses to the Philippines, including nearly 25 million doses provided by the American people.
“Thanks to recent deliveries, the COVAX facility and the United States have exceeded our goal of providing enough doses to vaccinate one-in-five Filipinos. We will continue to provide more safe and effective life-saving vaccines to our Filipino friends, partners, and allies as we work to end the COVID-19 pandemic together,” said U.S. Embassy in the Philippines Chargé d’Affaires ad interim Heather Variava.
The United States is working closely with Philippine partners to protect public health and support the local response to COVID-19. In addition to vaccine donations, the U.S. government has also provided more than Php1.9 billion ($39 million) in COVID-19 assistance to the Philippines to support testing, crucial care, communication campaigns, protection and training of health workers, vaccine deployment, and essential equipment and supplies.
To learn more about the U.S. government and American companies’ COVID-19 assistance to the Philippines, visit https://ph.usembassy.gov/fact-sheet-us-covid-19-assistance-to-the-philippines/.